Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jun 26, 2026
Biren Amin's Stock Ratings
Piper Sandler Analyst
Biren Amin is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
0.20%
Smart Score
Overall Average Return Percentile
35th
Number of Ratings
78
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/26/2026 | CNTB | Buy Now | Connect Biopharma Hldgs | $2.17 | 222.58% | → $7 | Initiates | Neutral → Overweight | Get Alert | |
| 05/18/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.09 | 35.05% | $875 → $855 | Maintains | Overweight | Get Alert | |
| 05/13/2026 | SLDB | Buy Now | Solid Biosciences | $9.41 | 91.19% | $17 → $18 | Maintains | Overweight | Get Alert | |
| 05/12/2026 | LENZ | Buy Now | LENZ Therapeutics | $5.80 | 106.9% | $39 → $12 | Downgrade | Overweight → Neutral | Get Alert | |
| 05/05/2026 | ACRS | Buy Now | Aclaris Therapeutics | $5.00 | 120% | $7 → $11 | Maintains | Overweight | Get Alert | |
| 03/31/2026 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.09 | 38.21% | → $875 | Assumes | Overweight → Overweight | Get Alert | |
| 03/24/2026 | CNTX | Buy Now | Context Therapeutics | $0.59 | 1087.45% | $4 → $7 | Maintains | Overweight | Get Alert | |
| 03/16/2026 | IMTX | Buy Now | Immatics | $9.38 | 91.9% | → $18 | Assumes | → Buy | Get Alert | |
| 03/13/2026 | ALLO | Buy Now | Allogene Therapeutics | $2.12 | 277.36% | $7 → $8 | Maintains | Overweight | Get Alert | |
| 02/26/2026 | KYMR | Buy Now | Kymera Therapeutics | $108.12 | 29.49% | $125 → $140 | Maintains | Overweight | Get Alert | |
| 02/20/2026 | OKYO | Buy Now | OKYO Pharma | $1.52 | 360.53% | → $7 | Initiates | → Overweight | Get Alert | |
| 02/19/2026 | CATX | Buy Now | Perspective Therapeutics | $3.04 | 426.32% | → $16 | Initiates | → Overweight | Get Alert | |
| 11/25/2025 | IRD | Buy Now | Opus Genetics | $4.00 | 75% | → $7 | Initiates | → Overweight | Get Alert | |
| 11/05/2025 | AAPG | Buy Now | Ascentage Pharma Group | $17.02 | 182.02% | → $48 | Initiates | → Overweight | Get Alert | |
| 10/30/2025 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | -5.33% | $15 → $16 | Maintains | Neutral | Get Alert | |
| 10/30/2025 | BBIO | Buy Now | BridgeBio Pharma | $70.78 | 38.46% | $93 → $98 | Maintains | Overweight | Get Alert | |
| 10/10/2025 | LENZ | Buy Now | LENZ Therapeutics | $5.80 | 1055.17% | $51 → $67 | Maintains | Overweight | Get Alert | |
| 10/03/2025 | OCUL | Buy Now | Ocular Therapeutix | $9.88 | 213.77% | $21 → $31 | Maintains | Overweight | Get Alert | |
| 09/25/2025 | MNPR | Buy Now | Monopar Therapeutics | $87.68 | 8.35% | $76 → $95 | Maintains | Overweight | Get Alert | |
| 07/29/2025 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | -11.24% | $11 → $15 | Maintains | Neutral | Get Alert | |
| 07/22/2025 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | -34.91% | $18 → $11 | Maintains | Neutral | Get Alert | |
| 07/21/2025 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 6.51% | $32 → $18 | Maintains | Neutral | Get Alert | |
| 07/14/2025 | BBIO | Buy Now | BridgeBio Pharma | $70.78 | -3.93% | $63 → $68 | Maintains | Overweight | Get Alert | |
| 07/10/2025 | ACRS | Buy Now | Aclaris Therapeutics | $5.00 | 20% | → $6 | Assumes | → Overweight | Get Alert | |
| 06/26/2025 | CNTX | Buy Now | Context Therapeutics | $0.59 | 578.54% | $4.5 → $4 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/16/2025 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 113.02% | $70 → $36 | Downgrade | Overweight → Neutral | Get Alert | |
| 05/16/2025 | SLDB | Buy Now | Solid Biosciences | $9.41 | 80.57% | $20 → $17 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | ALLO | Buy Now | Allogene Therapeutics | $2.12 | 230.19% | $9 → $7 | Maintains | Overweight | Get Alert | |
| 05/07/2025 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 314.2% | $110 → $70 | Maintains | Overweight | Get Alert | |
| 04/30/2025 | BBIO | Buy Now | BridgeBio Pharma | $70.78 | -10.99% | $46 → $63 | Maintains | Overweight | Get Alert | |
| 04/21/2025 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 550.89% | $182 → $110 | Maintains | Overweight | Get Alert | |
| 04/14/2025 | LENZ | Buy Now | LENZ Therapeutics | $5.80 | 779.31% | $38 → $51 | Maintains | Overweight | Get Alert | |
| 03/31/2025 | CNTA | Buy Now | Centessa Pharmaceuticals | $40.65 | -6.52% | → $38 | Initiates | → Overweight | Get Alert | |
| 03/21/2025 | ELEV | Buy Now | Elevation Oncology | — | — | $10 → $0.7 | Downgrade | Overweight → Neutral | Get Alert | |
| 03/19/2025 | MNPR | Buy Now | Monopar Therapeutics | $87.68 | -13.32% | → $76 | Assumes | → Overweight | Get Alert | |
| 02/19/2025 | CMPX | Buy Now | Compass Therapeutics | $2.06 | 482.52% | → $12 | Initiates | → Overweight | Get Alert | |
| 02/06/2025 | VKTX | Buy Now | Viking Therapeutics | $37.92 | 87.24% | $74 → $71 | Maintains | Overweight | Get Alert | |
| 01/30/2025 | CRGX | Buy Now | Cargo Therapeutics | — | — | $34 → $4 | Downgrade | Overweight → Neutral | Get Alert | |
| 12/02/2024 | VKTX | Buy Now | Viking Therapeutics | $37.92 | 95.15% | → $74 | Initiates | → Overweight | Get Alert | |
| 12/02/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $8.60 | 306.98% | → $35 | Initiates | → Overweight | Get Alert | |
| 11/27/2024 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 976.92% | $200 → $182 | Maintains | Overweight | Get Alert | |
| 11/14/2024 | IMNM | Buy Now | Immunome | $19.96 | 5.21% | $23 → $21 | Maintains | Overweight | Get Alert | |
| 11/14/2024 | ALLO | Buy Now | Allogene Therapeutics | $2.12 | 324.53% | $11 → $9 | Maintains | Overweight | Get Alert | |
| 11/08/2024 | ACLX | Buy Now | Arcellx | — | — | $91 → $115 | Maintains | Overweight | Get Alert | |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | — | — | $40 → $32 | Maintains | Neutral | Get Alert | |
| 09/04/2024 | BBIO | Buy Now | BridgeBio Pharma | $70.78 | -35.01% | → $46 | Initiates | → Overweight | Get Alert | |
| 08/13/2024 | CRGX | Buy Now | Cargo Therapeutics | — | — | $37 → $34 | Maintains | Overweight | Get Alert | |
| 08/13/2024 | IMNM | Buy Now | Immunome | $19.96 | 15.23% | $27 → $23 | Maintains | Overweight | Get Alert | |
| 08/08/2024 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 1083.43% | $205 → $200 | Maintains | Overweight | Get Alert | |
| 07/19/2024 | AGEN | Buy Now | Agenus | $3.07 | 128.01% | $3 → $7 | Downgrade | Buy → Hold | Get Alert | |
| 07/01/2024 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 1113.02% | $205 → $205 | Maintains | Overweight | Get Alert | |
| 06/27/2024 | CRGX | Buy Now | Cargo Therapeutics | — | — | → $37 | Initiates | → Overweight | Get Alert | |
| 06/21/2024 | SLDB | Buy Now | Solid Biosciences | $9.41 | 112.44% | $20 → $20 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/21/2024 | OCUL | Buy Now | Ocular Therapeutix | $9.88 | 51.82% | $15 → $15 | Maintains | Overweight | Get Alert | |
| 06/21/2024 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 828.99% | $157 → $157 | Maintains | Overweight | Get Alert | |
| 05/31/2024 | SRPT | Buy Now | Sarepta Therapeutics | $16.90 | 828.99% | → $157 | Initiates | → Overweight | Get Alert | |
| 05/31/2024 | IMNM | Buy Now | Immunome | $19.96 | 35.27% | → $27 | Initiates | → Overweight | Get Alert | |
| 05/31/2024 | ELEV | Buy Now | Elevation Oncology | — | — | → $10 | Initiates | → Overweight | Get Alert | |
| 05/31/2024 | APLS | Buy Now | Apellis Pharmaceuticals | — | — | → $46 | Initiates | → Neutral | Get Alert | |
| 05/31/2024 | ALLO | Buy Now | Allogene Therapeutics | $2.12 | 418.87% | → $11 | Initiates | → Overweight | Get Alert | |
| 05/31/2024 | ACLX | Buy Now | Arcellx | — | — | → $70 | Initiates | → Overweight | Get Alert | |
| 05/19/2023 | ZNTL | Buy Now | Zentalis Pharma | $3.95 | 1672.15% | $120 → $70 | Maintains | Buy | Get Alert | |
| 02/17/2021 | CRTX | Buy Now | Cortexyme | — | — | $59 → $34 | Downgrade | Buy → Hold | Get Alert | |
| 01/11/2021 | BCAB | Buy Now | BioAtla | $3.52 | 1348.86% | → $51 | Initiates | → Buy | Get Alert | |
| 11/13/2020 | UROV | Buy Now | Urovant Sciences | — | — | → $16.25 | Downgrade | Buy → Hold | Get Alert | |
| 10/30/2020 | ALDX | Buy Now | Aldeyra Therapeutics | $1.83 | 1211.48% | → $24 | Initiates | → Buy | Get Alert | |
| 10/19/2020 | TSHA | Buy Now | Taysha Gene Therapies | $6.28 | 441.4% | → $34 | Initiates | → Buy | Get Alert | |
| 09/14/2020 | KALA | Buy Now | Kala Pharmaceuticals | $2.60 | 284.62% | $21 → $10 | Downgrade | Buy → Hold | Get Alert | |
| 07/24/2020 | IMTX | Buy Now | Immatics | $9.38 | 49.25% | → $14 | Initiates | → Buy | Get Alert | |
| 07/14/2020 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | → $54 | Initiates | → Buy | Get Alert | |
| 06/12/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.09 | 9.15% | $657 → $691 | Maintains | Buy | Get Alert | |
| 06/02/2020 | CRTX | Buy Now | Cortexyme | — | — | → $59 | Initiates | → Buy | Get Alert | |
| 06/01/2020 | CTMX | Buy Now | CytomX Therapeutics | $3.39 | 194.99% | $16 → $10 | Downgrade | Buy → Hold | Get Alert | |
| 04/28/2020 | ZNTL | Buy Now | Zentalis Pharma | $3.95 | 937.97% | → $41 | Initiates | → Buy | Get Alert | |
| 03/27/2020 | CALA | Buy Now | Calithera Biosciences | $0.00 | 1499900% | → $6 | Initiates | → Buy | Get Alert | |
| 02/25/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.09 | -22.29% | $355 → $492 | Upgrade | Hold → Buy | Get Alert | |
| 12/19/2019 | THOR | Buy Now | Synthorx | $25.01 | 171.89% | $23 → $68 | Downgrade | Buy → Hold | Get Alert | |
| 09/16/2019 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | → $11 | Assumes | → Hold | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved